AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Methods for Estimating Population Size for Key Populations: A Global Scoping Review For HIV ResearchView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021The Implications of Adverse Effects With Tdf/FTC on the Implementation of Pre-Exposure Prophylaxis Against HIVView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Preference for Long-Acting Injectable Pre-Exposure Prophylaxis Among Transgender Women Clients of the Tangerine Clinic in Bangkok, ThailandView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Unmet Health Needs and Gender Minority Stress Among Transgender Individuals: A Cross-Sectional Study in ChinaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Missing Pieces of Quality of life in PWH: Psychological and Mental HealthView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Short-Term Outcomes of Plwh Adopting Rapid Initiation of Antiretroviral Therapy (Art) At a University Hospital in Taiwan During 2019-2020View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Real-World Data on the Use of Dolutegravir (Dtg) + Lamivudine (3tc) In Art-NAïve and Pre-Treated HIV-Infected Patients in ChinaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Impact of HIV- Related Stigma on Willing to care PLWH among Nurses during the COVID-19 Pandemic in TaiwanView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Impact of COVID-19 on Key Populations and People Living With HIV in Vietnam: Economic Hardship and Reduced Psychosocial WellbeingView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021BMI as a Predictor of High Fasting Blood Glucose Among People Living With HIV in the Asia-Pacific RegionView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Dolutegravir Plus Lamivudine Dual Therapy in Treatment naïve HIV-1 patients：Preliminary Data from Real-worldView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Real-World Same Day ART to Achieve Rapid U=U, VGH-TC ExperienceView Abstract
